Viewing nowHuresto 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Hubist Pharmaceutical Co., Ltd.

MFDS item code 201404928 · Approved 2014.10.27 · Insurance code 628800360
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is primarily used in patients with hypercholesterolemia and hyperlipidemia. It is effective for patients with primary hypercholesterolemia and mixed dyslipidemia that are difficult to manage with diet and exercise and is used in conjunction with other treatments for homozygous familial hypercholesterolemia patients. This drug lowers total cholesterol and LDL cholesterol levels and delays the progression of atherosclerosis. It is also used as an adjunct to dietary therapy in children aged 10 years and older with familial hypercholesterolemia. It is beneficial for patients with primary dysbetalipoproteinemia. In particular, it contributes to reducing the risk of stroke, myocardial infarction, and vascular revascularization in high-risk men and women with elevated high-sensitivity C-reactive protein levels and cardiovascular disease risk factors. This drug improves the risk factors for hyperlipidemia and cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this medicine at 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin did not increase in patients with a Child-Pugh score of 7 or less, but increased in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, it should not be administered to patients with allergies to its components, severely impaired liver function, muscle diseases, those taking specific immunosuppressants, those with severely reduced kidney function, pregnant or nursing women, and those at risk for muscle disease. Caution should be exercised when administering this drug to patients with compromised liver function or those who consume large amounts of alcohol, and it is advisable to perform repeat liver function tests before and during treatment. Additionally, if symptoms of muscle pain or weakness occur, medical personnel should be notified immediately and an examination should be conducted. Patients at high risk of muscle damage, such as those with kidney disorders, hypothyroidism, a family history or past incidents of muscle toxic reactions, the elderly, and those with alcohol abuse, should use this drug with increased caution and regular muscle-related examinations are necessary. This drug contains lactose and should not be administered to patients with lactose intolerance. While taking this drug, rare side effects such as headache, dizziness, indigestion, skin rash, and muscle pain may occur, and in severe cases, serious muscle damage such as myositis or rhabdomyolysis may develop. Pregnant or nursing women should not take this medication, and women who might become pregnant should use appropriate contraception. This drug may interact with other medications, so caution is required, especially when taken with specific antiviral drugs, immunosuppressants, antibiotics, and fibrate medications. When taken with certain drugs, the blood concentration of this medication may increase, raising the risk of muscle damage. In case of overdose, there is no specific antidote, and symptom-based treatment and liver function and muscle enzyme examinations are necessary. Caution should be exercised as dizziness may occur during driving or operating machinery. If severe skin reactions, liver function abnormalities, severe muscle pain, or other abnormal symptoms occur while taking this drug, consumption should be stopped immediately, and medical personnel should be consulted.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbance, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to store it at normal room temperature between 1°C and 30°C, avoiding excessively hot or cold environments.
Yellow round film-coated tablet
PTP - 30 tablets/PTP [(15 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Hubist Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.